PubRank

R L Powles

Author PubWeight™ 93.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980 4.21
2 Management of adult acute myelogenous leukaemia. Br Med J 1973 3.33
3 Immunotherapy for acute myelogenous leukaemia. Br J Cancer 1973 2.67
4 Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J 1971 2.50
5 Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet 1979 2.48
6 High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983 2.33
7 The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet 1980 2.03
8 Parenteral acyclovir therapy for herpesvirus infections in man. Lancet 1979 1.99
9 Outcome of biphenotypic acute leukemia. Haematologica 1999 1.46
10 Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant 1999 1.45
11 Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer 1977 1.43
12 Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med 1998 1.42
13 Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000 1.36
14 Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983 1.31
15 Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994 1.29
16 Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men. Br Med J 1976 1.26
17 Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J 1974 1.15
18 Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. Br J Haematol 1997 1.14
19 Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed) 1982 1.13
20 A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 2006 1.12
21 Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 1987 1.11
22 Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes. Postgrad Med J 1987 1.10
23 HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy. Transplantation 1975 1.08
24 Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant 1988 1.07
25 Some properties of cryopreserved acute leukemia cells. Cryobiology 1973 1.05
26 Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma 2000 1.05
27 Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993 0.97
28 Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 1995 0.96
29 Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys 1983 0.96
30 Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol 1980 0.96
31 Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol 1998 0.94
32 Amino (hydroxyethoxymethyl) purine: a new well-absorbed prodrug of acyclovir. Lancet 1984 0.94
33 Disturbance of blood-brain barrier after bone-marrow transplantation. Lancet 1985 0.93
34 Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients. J Clin Pathol 1984 0.93
35 Immunotherapy in the management of acute leukaemia. Br J Haematol 1976 0.92
36 Guillain-Barré syndrome associated with chronic lymphatic leukaemia. Br Med J 1967 0.92
37 A practical guide to granulocyte transfusion therapy. J Clin Pathol 1976 0.91
38 Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 1983 0.91
39 A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients. J Virol Methods 1996 0.90
40 Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin. Leukemia 1994 0.90
41 Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1999 0.89
42 Acute erythroid leukemia (M6): outcome of bone marrow transplantation. Leuk Lymphoma 1999 0.89
43 A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Leuk Lymphoma 1997 0.89
44 Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. J Clin Virol 2002 0.87
45 The relationship between serum viscosity, hypervolaemia and clinical manifestations associated with circulating paraprotein. Br J Haematol 1978 0.86
46 Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. Blood 1997 0.86
47 Histopathology of the lung after bone marrow transplantation. J Clin Pathol 1983 0.86
48 The nature of remission in acute myeloblastic leukaemia. Lancet 1979 0.85
49 Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. Am J Med 1988 0.85
50 Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes. BMJ 1991 0.85
51 Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AML. Bone Marrow Transplant 1998 0.85
52 The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer 1989 0.84
53 Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry. Br J Haematol 1998 0.82
54 Letter: neuropathy due to cytosine arabinoside. Br Med J 1974 0.82
55 Cytokine gene expression in skin and lymphoid organs in graft versus host disease. J Clin Pathol 1993 0.82
56 GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 1996 0.82
57 Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD). Bone Marrow Transplant 1999 0.82
58 Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice. Br J Haematol 1998 0.80
59 Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia. Br J Cancer 1977 0.80
60 Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. Leuk Res 1985 0.80
61 Cimetidine-induced myelosuppression after bone marrow transplantation. Leuk Lymphoma 1994 0.80
62 Cost of bone-marrow transplants in acute myeloid leukaemia. Lancet 1980 0.80
63 Thalidomide for chronic GVHD. Bone Marrow Transplant 1998 0.79
64 Liver disease after bone marrow transplantation. Gut 1982 0.79
65 Antifungal prophylaxis in bone marrow transplantation. Rev Infect Dis 1990 0.79
66 Quantification of cytomegalovirus DNA in blood specimens from bone marrow transplant recipients by the polymerase chain reaction. J Virol Methods 1994 0.78
67 Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet 1982 0.78
68 Chimerism in skin of bone marrow transplant recipients. Transplantation 1984 0.78
69 Paraplegia after intrathecal mitozantrone. Lancet 1986 0.78
70 Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b. Br J Cancer 1994 0.78
71 Ratio of blood and marrow-derived cells in bone marrow transplantation. J Clin Pathol 1982 0.77
72 Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cells. Lancet 1977 0.77
73 Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin. Leukemia 1994 0.77
74 Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma. Leuk Lymphoma 1999 0.77
75 The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue. Bone Marrow Transplant 1998 0.76
76 Fatal pneumococcal infections following allogeneic bone marrow transplant. Bone Marrow Transplant 1994 0.76
77 Immunotherapy for acute myelogenous leukemia. Bibl Haematol 1975 0.76
78 Impact of previous high-dose therapy on outcome after allografting for multiple myeloma. Bone Marrow Transplant 1999 0.76
79 Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group. Bone Marrow Transplant 1997 0.76
80 Colony-forming ability of marrow from patients receiving immunotherapy during chemotherapy-induced remission in acute myeloid leukaemia. J Clin Pathol 1977 0.75
81 Leukaemic relapse following Campath 1 treated bone marrow transplantation for leukaemia. Lancet 1986 0.75
82 Minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998 0.75
83 Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy. Br J Cancer 1996 0.75
84 The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor. Br J Cancer 1989 0.75
85 Cyclosporin A as prophylaxis against graft-versus-host disease. Br Med J (Clin Res Ed) 1982 0.75
86 Plasma exchange v peritoneal dialysis for removing Bence Jones protein. Br Med J 1978 0.75
87 Cyclosporine--a model for the testing of bio-immunological reaction modifiers in man. Med Oncol Tumor Pharmacother 1984 0.75
88 Transplantation of autologous peripheral blood stem cells mobilized using GM-CSF for acute leukemia with myelofibrosis. Leuk Lymphoma 1993 0.75
89 Pitfalls in analysis of survival in clinical trials. Biomedicine 1976 0.75
90 Prevention of graft versus host disease following allogeneic bone marrow transplantation. Tokai J Exp Clin Med 1985 0.75
91 Bone-marrow transplantation in leukaemia remission. Lancet 1982 0.75
92 Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission. Haematol Blood Transfus 1981 0.75
93 Reducing the normal circulating hematopoietic inhibitor level using cytotoxic drugs or silver nitrate. A comparison with the effect of interleukin-1. Ann N Y Acad Sci 1991 0.75
94 Limited activity of ICRF-159 in advanced acute leukemia. Cancer Treat Rep 1979 0.75
95 Idarubicin for remission induction of acute myeloid leukemia: United Kingdom multicenter experience. Semin Oncol 1993 0.75
96 Deficiency of autologous mixed lymphocyte reaction in long-term bone marrow transplant recipients without clinical chronic graft versus host disease. Haematologica 1988 0.75
97 Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro. Exp Hematol 1992 0.75
98 Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth-promoting activity. Br J Haematol 1990 0.75
99 Immunologic maneuvers in the management of acute leukemia. Med Clin North Am 1976 0.75
100 Intrathecal mitozantrone for resistant leukaemia. Lancet 1985 0.75
101 Inhibition of human leukaemic thymidylate kinase and L1210 ribonucleotide reductase by dinucleotides of adenosine and thymidine and their phosphonate analogues. Biochem Pharmacol 1988 0.75
102 Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. Bone Marrow Transplant 2006 0.75
103 Leukaemic relapse after Campath 1 treated bone marrow transplantation for leukaemia. Lancet 1986 0.75
104 Possible role of person-to-person transmission of Listeria infection in immunocompromised patients. Lancet 1989 0.75
105 Growth of xenografted human bone marrow: comparison with hemopoietic reconstitution in patients after allogeneic bone marrow transplant and response to granulocyte macrophage colony stimulating factor. Leukemia 1989 0.75
106 Interferon-gamma+ and interleukin-2+ T cells in peripheral blood from multiple myeloma patients in relation to disease status and maintenance therapy with interferon-alpha2b (intron A). Br J Haematol 1997 0.75
107 Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994 0.75
108 [Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)]. Minerva Med 1977 0.75
109 Lymphocytotoxic antibodies in leukemic patients treated with bone marrow transplantation. Transplantation 1985 0.75
110 Uses of the NCI-IBM cell separator. Br J Haematol 1971 0.75
111 The use of the NAG random number generating routines in simulated survival studies. Biomedicine 1978 0.75
112 Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation. Bone Marrow Transplant 1989 0.75
113 TGF beta 1 and IL-4 have opposing effects on the proliferation of chronic phase chronic myeloid leukaemic cells stimulated by G-CSF in vitro. Leuk Lymphoma 1994 0.75
114 Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia. Bone Marrow Transplant 1999 0.75
115 The place of immunological methods of treatment in the management of acute leukaemia. Hamatol Bluttransfus 1976 0.75
116 Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine. Lancet 1986 0.75
117 Cyclosporin A following matched and mismatched family allogeneic bone marrow transplants. Haematol Blood Transfus 1983 0.75
118 Bone-marrow transplants in leukaemia. Lancet 1980 0.75
119 Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy. Exp Hematol 1993 0.75
120 Total body irradiation and marrow transplantation for acute leukaemia. The Royal Marsden Hospital experience. Pathol Biol (Paris) 1979 0.75
121 Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia. Blood 1996 0.75
122 Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet 1980 0.75
123 Cyclosporin A in human bone marrow grafts. Haematol Blood Transfus 1980 0.75
124 One haplotype matched bone marrow grafts: an investigation using the HLA system as a marker of cellular origin. Dis Markers 1988 0.75
125 Antagonism of the inhibitory effects of transforming growth factor-beta on colony formation of mouse bone marrow cells in vitro by increasing concentrations of growth factors. Ann N Y Acad Sci 1991 0.75
126 High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transplant 1991 0.75
127 The application of immunotherapy to the treatment of cancer. Pharmacol Ther 1979 0.75
128 Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue. Bone Marrow Transplant 1996 0.75
129 Acute myelomonocytic leukemia with t(10;11)(p13;q23): heterogeneity of breakpoints at 11q23 and association with recombinase activation. Genes Chromosomes Cancer 1994 0.75
130 Cytogenetic follow-up studies of recipients of T-cell depleted allogeneic bone marrow. Br J Haematol 1987 0.75
131 Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transplant 1990 0.75
132 Infections after bone marrow transplantation using cyclosporine. Transplantation 1983 0.75
133 Cytogenetic studies using Q-band polymorphisms in patients with AML receiving marrow from like-sex donors. Hum Genet 1987 0.75
134 Razoxane and T-cell lymphoma. Br J Dermatol 1989 0.75
135 Acute myeloid leukaemia: comparison of support required during initial induction of remission and marrow transplantation in first remission. Lancet 1981 0.75
136 The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. J Investig Med 1995 0.75
137 Radiation damage in patients treated by total-body irradiation, bone marrow grafting, and cyclosporin. Radiat Res 1986 0.75